Jpmorgan Chase & Co »

Corvus Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $94k 53k 1.78
2023-12-31 $1.2k 679 1.76
2023-09-30 $102k 70k 1.46
2023-06-30 $2.8k 1.2k 2.29
2023-03-31 $999 1.2k 0.83
2022-12-31 $999 1.2k 0.83
2022-06-30 $2.0k 2.0k 1.02
2022-03-31 $9.0k 5.5k 1.64
2021-12-31 $10k 4.1k 2.44
2019-06-30 $226k 67k 3.39
2019-03-31 $672k 167k 4.02
2018-12-31 $842k 229k 3.67
2018-09-30 $1.0M 118k 8.65
2018-06-30 $1.3M 115k 11.01
2018-03-31 $2.5M 218k 11.53
2017-12-31 $2.6M 246k 10.42
2017-06-30 $4.0M 333k 12.11
2017-03-31 $3.2M 154k 20.78
2016-12-31 $2.6M 180k 14.29
2016-09-30 $2.7M 165k 16.45
2016-06-30 $2.5M 175k 14.26